Cargando…

Ipilimumab-induced renal granulomatous arteritis: a case report

BACKGROUND: Immune Checkpoint Inhibitors (ICPIs) are promising new drugs in treatment of advanced tumours targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed cell death protein-1 (PD1) or its ligand (PDL-1). Ipilimumab is a monoclonal antibody targeting the CTLA-4 receptor used in tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lemoine, Mathilde, Dilly, Baptiste, Curie, Alexandre, Hébert, Vivien, Laurent, Charlotte, Hanoy, Mélanie, Grangé, Steven, Guerrot, Dominique, François, Arnaud, Bertrand, Dominique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788031/ https://www.ncbi.nlm.nih.gov/pubmed/31604452 http://dx.doi.org/10.1186/s12882-019-1552-2

Ejemplares similares

Efficacy of anti–SARS-CoV-2 monoclonal antibody prophylaxis and vaccination on the Omicron variant of COVID-19 in kidney transplant recipients
por: Bertrand, Dominique, et al.
Publicado: (2022)

Waning antibody response and cellular immunity 6 months after third dose SARS-Cov-2 mRNA BNT162b2 vaccine in kidney transplant recipients
por: Bertrand, Dominique, et al.
Publicado: (2022)

Monitoring of hemodialysis quality-of-care indicators: why is it important?
por: Grangé, Steven, et al.
Publicado: (2013)

Haemodialysis catheterization via type II persistent left superior vena cava
por: Guerrot, Dominique, et al.
Publicado: (2008)

Antibody response to SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients and in-centre and satellite centre haemodialysis patients
por: Bertrand, Dominique, et al.
Publicado: (2021)

SARS-CoV-2–specific Humoral and Cellular Immunities in Kidney Transplant Recipients and Dialyzed Patients Recovered From Severe and Nonsevere COVID-19
por: Bertrand, Dominique, et al.
Publicado: (2021)

Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients
por: Bertrand, Dominique, et al.
Publicado: (2021)

Cobalamin C Deficiency Induces a Typical Histopathological Pattern of Renal Arteriolar and Glomerular Thrombotic Microangiopathy
por: Lemoine, Mathilde, et al.
Publicado: (2018)

Conversion From Intravenous In-Hospital Belatacept Injection to Subcutaneous Abatacept Injection in Kidney Transplant Recipients During the First COVID-19 Stay-at-Home Order in France
por: Bertrand, Dominique, et al.
Publicado: (2023)

von Brünn Nests Hyperplasia as a Cause of Ureteral Stenosis After Kidney Transplantation
por: Hamzaoui, Mouad, et al.
Publicado: (2016)

Campylobacter fetus bacteremia complicated by multiple splenic abscesses and multivisceral signs in a renal transplant recipient: a case report and review of the literature
por: Coustillères, François, et al.
Publicado: (2022)

Risk Factors for Early Graft Failure and Death After Kidney Transplantation in Recipients Older Than 70 Years
por: Lemoine, Mathilde, et al.
Publicado: (2019)

Humoral response to a fourth dose of mRNA vaccine in kidney transplant recipient responders to three doses of mRNA vaccine
por: de Nattes, Tristan, et al.
Publicado: (2022)

Adrenocortical carcinoma complicated by renal thrombotic microangiopathy, a case-series
por: de Nattes, Tristan, et al.
Publicado: (2020)

Correction to: Adrenocortical carcinoma complicated by renal thrombotic microangiopathy, a case-series
por: de Nattes, Tristan, et al.
Publicado: (2020)

Clinical Value of Natriuretic Peptides in Predicting Time to Dialysis in Stage 4 and 5 Chronic Kidney Disease Patients
por: Sundqvist, Sofia, et al.
Publicado: (2016)

Granulomatous arteritis limited to the skin: case report and etiologic differential diagnosis()
por: Silva, Diego Henrique Morais, et al.
Publicado: (2022)

Autoimmune Granulomatous Inflammation of Lacrimal Glands and Axonal Neuritis Following Treatment With Ipilimumab and Radiation Therapy
por: Ileana Dumbrava, Ecaterina, et al.
Publicado: (2018)

Prognostic Value of C4d Immunolabelling in Adult Patients With IgA Vasculitis
por: Romero, Anais, et al.
Publicado: (2021)

Intensity of de novo DSA detected by Immucor Lifecodes assay and C3d fixing antibodies are not predictive of subclinical ABMR after Kidney Transplantation
por: Bertrand, Dominique, et al.
Publicado: (2021)

Unique case of granulomatous arteritis in a grey mouse lemur (Microcebus murinus) – first case description
por: Cichon, Nicole, et al.
Publicado: (2017)

Hemolysis induced by Left Ventricular Assist Device is associated with proximal tubulopathy
por: de Nattes, Tristan, et al.
Publicado: (2020)

Ipilimumab
Publicado: (2012)

Intimal granulomatous angiitis in sarcoid pulmonary vasculitis: worth remembering
por: Bernaudin, Jean-François, et al.
Publicado: (2023)

Incidence, predictors and prognostic impact of acute kidney injury in patients with COVID-19
por: Saeed, Sahrai, et al.
Publicado: (2022)

Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre
por: Grall, Maximilien, et al.
Publicado: (2021)

Combined Nivolumab and Ipilimumab in Octogenarian and Nonagenarian Melanoma Patients
por: Reichert, Constance, et al.
Publicado: (2023)

Granulomatous Inflammation and Hypercalcemia in Patients With Severe Systemic Oxalosis
por: Perrin, Peggy, et al.
Publicado: (2021)

Adequacy between practice and European guidelines on hyponatremia: a survey among French nephrologists
por: Martzloff, Jonas, et al.
Publicado: (2022)

The Spectrum of Kidney Pathology in B-Cell Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma: A 25-Year Multicenter Experience
por: Poitou-Verkinder, Anne-Laure, et al.
Publicado: (2015)

Long-term real-world experience with ipilimumab and non-ipilimumab therapies in advanced melanoma: the IMAGE study
por: Dalle, Stéphane, et al.
Publicado: (2021)

Ipilimumab: Melanoma and beyond
por: Patel, Vishal, et al.
Publicado: (2011)

Patterns of response with talimogene laherparepvec in combination with ipilimumab or ipilimumab alone in metastatic unresectable melanoma
por: Chesney, Jason, et al.
Publicado: (2019)

Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab
por: Chapman, Paul B, et al.
Publicado: (2021)

Progression of renal fibrosis: the underestimated role of endothelial alterations
por: Guerrot, Dominique, et al.
Publicado: (2012)

Use of ipilimumab in the treatment of melanoma
por: Acharya, Utkarsh H, et al.
Publicado: (2013)

Ipilimumab-induced colonic perforation
por: Burdine, Lyle, et al.
Publicado: (2014)

Ipilimumab-Induced Neutropenia in Melanoma
por: Ban-Hoefen, Makiko, et al.
Publicado: (2016)

Ipilimumab induced digital vasculitis
por: Padda, Amrita, et al.
Publicado: (2018)

In Reply to “Letter Regarding ‘Granulomatous Inflammation and Hypercalcemia in Patients With Severe Systemic Oxalosis’”
por: Perrin, Peggy, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m903ec77fu3bsqkcnk9nsr0nug